Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05183997
Other study ID # vsbpb
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2022
Est. completion date February 2023

Study information

Verified date January 2022
Source Assiut University
Contact Essam Sharkawy, MD
Phone 00201223497642
Email essamsas@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Supraclavicular brachial plexus block (SCBPB) is the common approach to provide surgical anesthesia of upper limb. The effects of single-injection brachial plexus nerve blocks recede after several hours unmasking the moderate to- severe pain of the surgical insult.


Description:

Strategies to prolong brachial plexus nerve blocks analgesia beyond the pharmacological duration of the local anaesthetic used include placement of indwelling perineural catheters to allow prolonged infusion or the co-administration of adjuvants such as epinephrine, a2 agonists (i.e. clonidine and dexmedetomidine), midazolam, or the corticosteroid dexamethasone. The investigators will use calcium channel blocker as adjuvant to bupivacaine in supraclavicular block. Calcium plays an important role in analgesia produced by local anesthetics. The activation of N-methyl-D-aspartate receptors may lead to calcium entry into cells and potentiation of spinal cord and plays a role in pain formation. Hence, calcium channel blockers may prevent central sensitization and provide better sensory motor block characteristics. Verapamil, a calcium channel blocker can potentiate analgesic action of local anesthetics and reduce postoperative pain and analgesic consumption. Few studies were there using 2.5 mg of verapamil, showing no effect on onset and duration of sensory motor block. Hence, the investigators have used 5 mg of verapamil as adjuvant to bupivacaine. The primary aim of the study was to know whether verapamil (5 mg) as adjuvant to bupivacaine in supraclavicular brachial plexus block would delay the need of rescue analgesia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date February 2023
Est. primary completion date February 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - ASA I-II patients older than 18years and scheduled for forearm and hand surgeries like : 1. fracture radius and ulna. 2. cut wrists. Exclusion Criteria: 1. allergy to the study drugs, 2. skin infection at site of needle puncture, 3. significant organ dysfunction, coagulopathy, drug or alcohol abuse, epilepsy, and psychiatric illness that would interfere with perception and assessment of pain.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
complete blood count
laboratory test
prothrombin time
laboratory test
prothrombin concentration
laboratory test
Drug:
Verapamil
drug will be add to prolong the effect of regional block

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (5)

Brose WG, Gutlove DP, Luther RR, Bowersox SS, McGuire D. Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain. Clin J Pain. 1997 Sep;13(3):256-9. — View Citation

Choi S, Rodseth R, McCartney CJ. Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2014 Mar;112(3):427-39. doi: 10.1093/bja/aet417. Epub 2014 Jan 10. Review. — View Citation

Knezevic NN, Anantamongkol U, Candido KD. Perineural dexamethasone added to local anesthesia for brachial plexus block improves pain but delays block onset and motor blockade recovery. Pain Physician. 2015 Jan-Feb;18(1):1-14. Review. — View Citation

Malmberg AB, Yaksh TL. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci. 1994 Aug;14(8):4882-90. — View Citation

Pöpping DM, Elia N, Marret E, Wenk M, Tramèr MR. Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks: a meta-analysis of randomized trials. Anesthesiology. 2009 Aug;111(2):406-15. doi: 10.1097/ALN.0b013e3181aae897. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary duration of postoperative analgesia. blinded observer will collect the Visual Analogue Score (VAS) for pain scored from Zero to ten where 0= no pain and 10 = the worst pain imaginable for acute post-operative pain. in first 24 hours
See also
  Status Clinical Trial Phase
Completed NCT06005480 - Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers Phase 1
Completed NCT04565093 - Efficacy of iPACK After Unilateral TKA N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Completed NCT02524652 - Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction Phase 4
Completed NCT03913429 - Ultrasound-guided Bilateral Suprazygomatic Maxillary Nerve Block and Bimaxillary Osteotomy N/A
Completed NCT05012332 - Local Anesthesia Spread After an Erector Spinae Plane Block. N/A
Withdrawn NCT04015284 - Intraoperative Pain and Quality of Surgical Block During Shoulder Surgery Assessed by NOL Index N/A
Recruiting NCT05432934 - Transversus Abdominis Plane Blocks With and Without Dexamethasone Phase 1/Phase 2
Recruiting NCT05512897 - Does ESP Block Reduce Pain and Opiates Consumption After Surgery N/A
Completed NCT04085263 - Rhomboid Intercostal and Subserratus Plane Block N/A
Not yet recruiting NCT04001387 - Feasibility of Real-time Ultrasound-guided Spinal Anesthesia Using Dynamic Needle Tip Positioning
Active, not recruiting NCT05478629 - Safety of Regional Anesthesia in Ukraine: the Survey
Terminated NCT03296033 - Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin Phase 4
Withdrawn NCT02603900 - Adductor Canal Catheter vs Local Infiltration of Analgesia for Total Knee Arthroplasty Phase 4
Completed NCT03666845 - Plasma Ropivacaine Concentrations After Sciatic Nerve Block in Patients With Chronic Kidney Disease
Completed NCT03394807 - LaGRA Trial in Laparoscopic Cholecystectomy Phase 4
Completed NCT05558449 - Impact of Virtual Reality Hypno-sedation on Functional Recovery and Anxiety in Foot Surgery With Regional Anesthesia Phase 4
Completed NCT02433561 - Intra- Versus Extraplexic Catheter Placement for Continuous Interscalene Brachial Plexus Block Phase 4
Recruiting NCT06147401 - Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA N/A